JENNIFER RAKE: Open Payments
NPI 1215447784 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 45 payments from 17 companies in 2025. Trend: 2023 $890 · 2024 $1,434 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $188 |
| PFIZER INC. | 7 | $159 |
| Astellas Pharma US Inc | 3 | $99 |
| Radius Health, Inc. | 3 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Lilly USA, LLC | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $32 |
Products named: ELIQUIS, REXULTI, Ozempic, Veozah, Wegovy, JARDIANCE, PREVNAR 20, XIFAXAN.
Industry payments across FL — which companies pay providers there.
